Pharmacogenetics of hypoglycemic agents
Despite the increase in the number of hypoglycemic agents, 35%–40% of patients with diabetes are unable to achieve adequate glycemic control. One of the reasons is the genetic heterogeneity of diabetes mellitus, requiring different treatment approaches; however, the individual metabolic features and...
Saved in:
| Main Authors: | Irina Vladimirovna Kononenko, Aleksandr Yuryevich Mayorov, Ekaterina Olegovna Koksharova, Marina Vladimirovna Shestakova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2015-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/7681 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
by: Ivan Ivanovich Dedov, et al.
Published: (2011-03-01) -
Hypoglycemic treatment of diabetic patients in the Emergency Department
by: Carmen Caballero Requejo, et al.
Published: (2016-05-01) -
Effects of Hypoglycemic Agents on The Musculoskeletal System: A Comprehensive Review
by: Zhao J, et al.
Published: (2025-07-01) -
EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2013-06-01) -
Let's Talk LMCC (S01E05): 37-2 Antihyperglycemic Agents
by: Meryem K. Talbo, et al.
Published: (2024-09-01)